Looking to block out the sun and add a stylish touch to your home? In this Home Zone project, we’re tackling window coverings ...

As the cold winter weather sets in, keeping your home warm and energy-efficient becomes a top priority. One of the biggest ...

It offers a variety of products, including faux wood, cellular, mini, vertical, vinyl and wood blinds. Shades are also available in cellular, roller, Roman, simply sheer, soft Roman and woven wood ...

A clever new set of glasses may offer new hope to people with macular degeneration. By copying the structure of a fly's eyes, ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

But have you ever tried eating actual honeycomb? Honeycomb is the hexagonal formation made of beeswax that houses bees and their honey, which some people tout as both a nutritious addition to your ...

Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.

New Brunswick-based Johnson & Johnson and Bedminster-based Intra-Cellular Therapies, Inc. have entered into a definitive agreement ...

After hours: January 15 at 4:00:17 PM EST Loading Chart for USM ...

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and ...

Honeycomb, made by honey bees, is a natural sweetener. It provides health benefits like promoting digestion, immune health and reducing inflammation. However, consuming it in excess can be harmful.

Johnson & Johnson and Intra-Cellular Therapies, Inc. have announced that they have entered into a definitive agreement under ...